An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab.

CONCLUSIONS: The identification of factors predictive of response to treatment may help in better understanding the response to golimumab and in identifying PsA patients that are most likely to achieve mMDA following therapy with golimumab. PMID: 31287400 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research